Nancy J Hutson
CIK 1379222 · last filed 2025-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$862.5K
Companies
7
Total Filings
105
Lifetime Open-Market Net
-$3.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCRX | Director | 99,138 | $8.70 | $862.5K | -$2.02M | 40 | 2025-06-16 |
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | 93,000 | $0.35 | $32.7K | $90.3K | 12 | 2024-06-21 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | 37,760 | $0.07 | $2.6K | $22.9K | 9 | 2022-05-20 |
| Endo International plc (ENDP) Delisted | Director | 117,140 | $0.29 | $34.3K | -$605.2K | 21 | 2021-06-15 |
| CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | Director | 0 | — | — | -$585.0K | 2 | 2015-01-21 |
| CUBIST PHARMACEUTICALS INC (CBST) Delisted | Director | 9,847 | — | — | -$834.4K | 13 | 2013-07-29 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Director | 0 | — | — | $98.4K | 7 | 2011-05-16 |
Recent Filings · Page 2 of 11
105 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-24 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | BCRX | Grant (A) | +12,866 | $0 | EDGAR |
| 2022-05-20 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Buy (P) | +3,000 | $9.2K | EDGAR |
| 2022-05-20 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-08 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Exer (M) | +33,760 | $84.2K | EDGAR |
| 2021-11-02 | Clearside Biomedical, Inc. (CLSD) Delisted | Exer (M) | +40,000 | $81.3K | EDGAR |
| 2021-10-19 | BCRX | Mixed | — | -$1.25M | EDGAR |
| 2021-08-19 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Buy (P) | +3,000 | $9.2K | EDGAR |
| 2021-08-17 | Clearside Biomedical, Inc. (CLSD) Delisted | Buy (P) | +3,000 | $17.0K | EDGAR |
| 2021-06-15 | Endo International plc (ENDP) Delisted | Mixed | +24,921 | -$144.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.